Polistena, B.; Spandonaro, F.; Capra, R.; Fantaccini, S.; Santoni, L.; Zimatore, G.; Gasperini, C. The Societal Impact of Treatment With Natalizumab of relapsing–remitting Multiple Sclerosis in Italian Clinical Practice: The Tysabri® PharmacoEconomics (TyPE) Study. Grhta 2019, 6.